GILEAD SCIENCES, INC. — Director's Dealing 2017

Aug 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-10

Reporting Person: YOUNG KEVIN (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-10	Common Stock	M	910	—	Acquired	7141	Direct
2017-08-10	Common Stock	F	453	$72.70	Disposed	6688	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-10	Restricted Stock Unit	$	M	910	Disposed		Common Stock (910)	Direct

Footnotes

F1: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.